Apoptotic Effects of Quercitrin on Dld-1 Colon Cancer Cell Line
| dc.contributor.author | Çinçin, Zeynep Birsu | |
| dc.contributor.author | Ünlü, Miray | |
| dc.contributor.author | Kıran, Bayram | |
| dc.contributor.author | Bireller, Elif Sinem | |
| dc.contributor.author | Baran, Yusuf | |
| dc.contributor.author | Çakmakoğlu, Bedia | |
| dc.coverage.doi | 10.1007/s12253-014-9825-3 | |
| dc.date.accessioned | 2017-04-27T07:28:07Z | |
| dc.date.available | 2017-04-27T07:28:07Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Quercetin, which is the most abundant bioflavonoid compound, is mainly present in the glycoside form of quercitrin. Although different studies indicated that quercitrin is a potent antioxidant, the action of this compound is not well understood. In this study, we investigated whether quercitrin has apoptotic and antiproliferative effects in DLD-1 colon cancer cell lines. Time and dose dependent antiproliferative and apoptotic effects of quercitrin were subsequently determined by WST-1 cell proliferation assay, lactate dehydrogenase (LDH) cytotoxicity assay, detection of nucleosome enrichment factor, changes in caspase-3 activity, loss of mitochondrial membrane potential (MMP) and also the localization of phosphatidylserine (PS) in the plasma membrane. There were significant increases in caspase-3 activity, loss of MMP, and increases in the apoptotic cell population in response to quercitrin in DLD-1 colon cancer cells in a time- and dose-dependent manner. These results revealed that quercitrin has antiproliferative and apoptotic effects on colon cancer cells. Quercitrin activity supported with in vivo analyses could be a biomarker candicate for early colorectal carcinoma. | en_US |
| dc.description.sponsorship | Istanbul University Scientific Research Projects (31162) | en_US |
| dc.identifier.citation | ÇinÇin, Z.B., Ünlü, M., Kıran, B., Bireller, E.S., Baran, Y., and Çakmakoğlu, B. (2014). Apoptotic effects of quercitrin on DLD-1 colon cancer cell line. Pathology and Oncology Research, 21(2), 333-338. doi:10.1007/s12253-014-9825-3 | en_US |
| dc.identifier.doi | 10.1007/s12253-014-9825-3 | |
| dc.identifier.doi | 10.1007/s12253-014-9825-3 | en_US |
| dc.identifier.issn | 1532-2807 | |
| dc.identifier.issn | 1219-4956 | |
| dc.identifier.issn | 1219-4956 | |
| dc.identifier.scopus | 2-s2.0-84938214197 | |
| dc.identifier.uri | https://doi.org/10.1007/s12253-014-9825-3 | |
| dc.identifier.uri | https://hdl.handle.net/11147/5417 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer Verlag | en_US |
| dc.relation.ispartof | Pathology and Oncology Research | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Antiproliferative | en_US |
| dc.subject | Apoptosis | en_US |
| dc.subject | Quercitrin | en_US |
| dc.subject | Colon cancer | en_US |
| dc.subject | Antineoplastic agent | en_US |
| dc.title | Apoptotic Effects of Quercitrin on Dld-1 Colon Cancer Cell Line | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.institutional | Ünlü, Miray | |
| gdc.author.institutional | Baran, Yusuf | |
| gdc.author.yokid | 119193 | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology. Molecular Biology and Genetics | en_US |
| gdc.description.endpage | 338 | en_US |
| gdc.description.issue | 2 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q3 | |
| gdc.description.startpage | 333 | en_US |
| gdc.description.volume | 21 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W2004947483 | |
| gdc.identifier.pmid | 25096395 | |
| gdc.identifier.wos | WOS:000354265700013 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.accesstype | GOLD | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 8.0 | |
| gdc.oaire.influence | 3.854512E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Membrane Potential, Mitochondrial | |
| gdc.oaire.keywords | Time Factors | |
| gdc.oaire.keywords | Dose-Response Relationship, Drug | |
| gdc.oaire.keywords | L-Lactate Dehydrogenase | |
| gdc.oaire.keywords | Caspase 3 | |
| gdc.oaire.keywords | Quercitrin | |
| gdc.oaire.keywords | Antineoplastic Agents | |
| gdc.oaire.keywords | Apoptosis | |
| gdc.oaire.keywords | Adenocarcinoma | |
| gdc.oaire.keywords | In Vitro Techniques | |
| gdc.oaire.keywords | Antioxidants | |
| gdc.oaire.keywords | Colon cancer | |
| gdc.oaire.keywords | Antineoplastic agent | |
| gdc.oaire.keywords | Cell Line, Tumor | |
| gdc.oaire.keywords | Colonic Neoplasms | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Quercetin | |
| gdc.oaire.keywords | Antiproliferative | |
| gdc.oaire.keywords | Cell Proliferation | |
| gdc.oaire.popularity | 2.0982174E-8 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 0301 basic medicine | |
| gdc.oaire.sciencefields | 0303 health sciences | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 1.14768317 | |
| gdc.openalex.normalizedpercentile | 0.76 | |
| gdc.openalex.toppercent | TOP 1% | |
| gdc.opencitations.count | 36 | |
| gdc.plumx.crossrefcites | 24 | |
| gdc.plumx.mendeley | 42 | |
| gdc.plumx.pubmedcites | 15 | |
| gdc.plumx.scopuscites | 37 | |
| gdc.scopus.citedcount | 37 | |
| gdc.wos.citedcount | 33 | |
| local.message.claim | 2022-06-13T12:10:48.474+0300 | * |
| local.message.claim | |rp03036 | * |
| local.message.claim | |submit_approve | * |
| local.message.claim | |dc_contributor_author | * |
| local.message.claim | |None | * |
| relation.isAuthorOfPublication.latestForDiscovery | 7bb863bb-9384-4a07-9fbb-b9c1ab7634a3 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4013-8abe-a4dfe192da5e |
